• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Catheters
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Injection Molding
    • Insert molding
    • Tools
  • Materials
    • Advanced Materials
    • Silicone
  • Research & Development
  • Suppliers

Limaca Medical endoscopic ultrasound biopsy device wins FDA breakthrough designation

May 2, 2022 By Danielle Kirsh

Precision GI Limaca MedicalLimaca Medical today announced that its Precision GI endoscopic ultrasound biopsy device has received FDA breakthrough device designation.

Israel-based Limaca Medical designed the endoscopic device to obtain tumor tissue within or adjacent to the gastrointestinal tract. Precision GI is deployed and operated through an instrument channel in the endoscope to biopsy a tumor.

Precision GI uses a unique motorized, automated rotational cutting needle for successful tissue acquisition. It obtains biopsies for definitive diagnosis of pancreatic cancer and other life-threatening GI cancers more quickly and less traumatically than gold-standard procedures, according to the company.

In a comparative feasibility clinical study, Precision GI demonstrated contiguous intact core tissue samples that were fully adequate for definitive diagnosis of pancreatic lesions, Limaca said. The clean, non-contaminated tissue samples had a high percentage of tumor content with less blood and extraneous fluids.

“We are pleased with the FDA’s decision to grant the breakthrough device designation to Precision GI,” CEO Carl Rickenbaugh said in a news release. “At Limaca, our vision is to ensure that endoscopic biopsies always achieve a definitive diagnosis to enable optimal and timely GI cancer treatment. We are dedicated to the mission to provide a far better endoscopic biopsy experience for the endoscopist and patient, with the goal to achieve a faster, more efficient biopsy yield with highly consistent results. With the breakthrough device designation, we look forward to accelerating our progress toward our goal of obtaining the FDA’s 510(k) clearance to bring Precision GI to patients in the US in the near future.”

Filed Under: Endoscopes Tagged With: Limaca Medical

Primary Sidebar

DeviceTalks Tuesdays

DeviceTalks Tuesdays
MDO ad

Stay Current

Need Medical Tubing news in a minute?
We Deliver!

Medical Tubing + Extrusion newsletter get you caught up on all the mission critical news you need in medical tubing. Sign up today.

Enews Sign up

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

Medical Tubing & Extrusion

Subscribe to our e-newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS